Neural Control of Kidney Blood Flow During Exercise in African American Adults

December 22, 2025 updated by: Rachel Drew, University of Massachusetts, Boston

Neurovascular Control of Renal Blood Flow During Exercise in African American Adults

The goal of this clinical trials is to learn if healthy young African American (AA) adults have a larger change in their kidney blood flow during exercise compared to White (W) adults. The main questions that this study aims to answer are:

  • Do healthy young AA adults have a larger decrease in kidney blood flow during exercise compared to W adults?
  • Do healthy young AA adults have a larger decrease in kidney blood flow during other types of stress compared to W adults?

During two visits in the research lab, participants will:

  • Perform a fitness test
  • Perform cycling exercise while lying down
  • Undergo a cold hand test
  • Perform a mental math test

Completing this clinical trial will help researchers to understand more about why many AA adults have heart and kidney problems, so future research can study ways to reduce the number of AA adults who have these health issues.

Study Overview

Detailed Description

African American (AA) adults have a greater prevalence of developing cardiovascular and renal disease (CVRD) than White (W) adults. Elevated sympathetic nervous system activity is associated with increased incidence of CVRD. Physical exertion, such as exercise, acutely increases sympathetic nervous system activity directed towards the kidneys, resulting in renal vasoconstriction and reduced renal blood flow (RBF). Limited research shows that healthy young AA adults exhibit exaggerated sympathetic responsiveness both at rest and during sympathetic activation, which may be a major contributor to the increased risk of CVRD in this population. However, the acute renal vasoconstrictor response to any sympathetic nervous system activation has not been investigated to date in AA adults. During sympathetic nervous system activation such as exercise, sympathetic outflow to the kidneys in AA adults might be exaggerated, contributing to greater renal vasoconstriction and a larger reduction in RBF. Over time, this exaggerated neurovascular response to sympathetic activation could have a negative cumulative effect on the kidneys, which could be a contributing factor to the greater incidence of CVRD in this population.

Therefore, this study aims to examine the renal vasoconstrictor response to sympathetic stressors in healthy AA adults prior to development of CVRD, which will be achieved via two Specific Aims. In Specific Aim 1, the investigators will test the hypothesis that the renal vasoconstrictor response to acute dynamic exercise is exaggerated in healthy young AA compared to W adults. Specifically, the investigators will measure RBF and blood pressure at rest and during cycling exercise to calculate renal vascular resistance responses to exercise, enabling us to test the hypothesis that healthy young AA adults exhibit an exaggerated renal vasoconstrictor response to acute cycling exercise compared to healthy young W adults. In Specific Aim 2, the investigators will test the hypothesis that the renal vasoconstrictor response to non-exercise sympathetic stressors is exaggerated in healthy young AA compared to W adults. Specifically, the investigators will measure RBF and blood pressure at rest and during a cold pressor and mental stress tests to calculate renal vascular resistance responses to these non-exercise sympathetic stressors, enabling us to test the hypothesis that healthy young AA adults exhibit exaggerated renal vasoconstrictor responses to non-exercise sympathetic stressors compared to healthy young W adults.

Using the highly innovative approach of Doppler ultrasound to measure RBF during exercise and non-exercise sympathetic stressors non-invasively and with high temporal resolution will enable us to assess the renal vasoconstrictor response to sympathetic stressors in healthy AA adults prior to development of CVRD, so the underlying integrative physiological responses to sympathetic activation in AA adults can be understood. Findings from this study in this understudied yet clinically significant area will contribute to the ultimate goal of creating and implementing treatment strategies to reduce the risk of developing CVRD in AA adults.

Study Type

Interventional

Enrollment (Estimated)

32

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Massachusetts
      • Boston, Massachusetts, United States, 02125
        • Recruiting
        • University of Massachusetts Boston
        • Contact:
        • Principal Investigator:
          • Rachel C Drew, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 35 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Self-report as either African American or White racial identity
  • Born in United States
  • Both biological parents identify as same racial identity as participant
  • Recreationally active (participating in physical activity for at least 20 minutes per day, at least three times per week, but not training for competitive events)
  • Fluent in English

Exclusion Criteria:

  • Hispanic or Latino
  • Females who are pregnant or lactating
  • Cardiovascular or renal disease
  • Hypertension (blood pressure of more than or equal to 130/80 mmHg)
  • Diabetes
  • Obesity (body mass index of more than or equal to 30 kg/m2)
  • Smoker/Tobacco user
  • Acute medical conditions
  • Taking prescribed cardiovascular, antihypertensive, or renal medications

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: African American Adults
African American adults will undergo the interventions of acute exercise, a cold pressor test, and a mental stress test while beat-to-beat renal blood flow velocity, mean arterial blood pressure, and heart rate are recorded.
Participants will lie in a semi-supine position with their feet attached to the pedals of a custom-arranged cycle ergometer. Participants' 40% heart rate reserve will be calculated, giving the target value to achieve during exercise based on appropriate resistance applied on the cycle ergometer, corresponding to a moderate exercise intensity. After a 5-minute resting baseline, participants will perform dynamic cycling exercise at steady state for up to 20 minutes. They will then stop exercising, and there will be a 5-minute recovery period. Beat-to-beat renal blood flow velocity (Doppler ultrasound), mean arterial blood pressure (finger photoplethysmographic cuff), and heart rate (electrocardiogram) will be recorded throughout. A rating of perceived exertion will be taken from participants during the last 30 seconds of steady-state cycling exercise.
Participants will lie in a semi-supine position, and after a 3-minute resting baseline, participants will have their hand immersed in ice water for 2 minutes. This cold pressor test represents the non-exercise, physical sympathetic stressor. Participants' hand will then be removed from the ice water, followed by a 3-minute recovery period. Beat-to-beat renal blood flow velocity (Doppler ultrasound), mean arterial blood pressure (finger photoplethysmographic cuff), and heart rate (electrocardiogram) will be recorded throughout. Ratings of hand pain and cold perception will be taken from participants during the last 30 seconds of the cold pressor test.
Participants will lie in a semi-supine position, and after a 3-minute resting baseline, participants will perform a mental arithmetic task for 5 minutes. This mental stress test represents the non-exercise, psychological sympathetic stressor. Participants will be instructed to subtract a given number from a randomly selected three-digit number and verbally state their answer and continue to do so for the duration of the test. Participants will be instructed to state their answers as quickly and accurately as possible. Participants will then stop the arithmetic task, and a 3-minute recovery period will follow. Beat-to-beat renal blood flow velocity (Doppler ultrasound), mean arterial blood pressure (finger photoplethysmographic cuff), and heart rate (electrocardiogram) will be recorded throughout. A rating of perceived stress will be taken from participants during the last 30 seconds of the mental stress test.
Experimental: White Adults
White adults will undergo the interventions of acute exercise, a cold pressor test, and a mental stress test while beat-to-beat renal blood flow velocity, mean arterial blood pressure, and heart rate are recorded.
Participants will lie in a semi-supine position with their feet attached to the pedals of a custom-arranged cycle ergometer. Participants' 40% heart rate reserve will be calculated, giving the target value to achieve during exercise based on appropriate resistance applied on the cycle ergometer, corresponding to a moderate exercise intensity. After a 5-minute resting baseline, participants will perform dynamic cycling exercise at steady state for up to 20 minutes. They will then stop exercising, and there will be a 5-minute recovery period. Beat-to-beat renal blood flow velocity (Doppler ultrasound), mean arterial blood pressure (finger photoplethysmographic cuff), and heart rate (electrocardiogram) will be recorded throughout. A rating of perceived exertion will be taken from participants during the last 30 seconds of steady-state cycling exercise.
Participants will lie in a semi-supine position, and after a 3-minute resting baseline, participants will have their hand immersed in ice water for 2 minutes. This cold pressor test represents the non-exercise, physical sympathetic stressor. Participants' hand will then be removed from the ice water, followed by a 3-minute recovery period. Beat-to-beat renal blood flow velocity (Doppler ultrasound), mean arterial blood pressure (finger photoplethysmographic cuff), and heart rate (electrocardiogram) will be recorded throughout. Ratings of hand pain and cold perception will be taken from participants during the last 30 seconds of the cold pressor test.
Participants will lie in a semi-supine position, and after a 3-minute resting baseline, participants will perform a mental arithmetic task for 5 minutes. This mental stress test represents the non-exercise, psychological sympathetic stressor. Participants will be instructed to subtract a given number from a randomly selected three-digit number and verbally state their answer and continue to do so for the duration of the test. Participants will be instructed to state their answers as quickly and accurately as possible. Participants will then stop the arithmetic task, and a 3-minute recovery period will follow. Beat-to-beat renal blood flow velocity (Doppler ultrasound), mean arterial blood pressure (finger photoplethysmographic cuff), and heart rate (electrocardiogram) will be recorded throughout. A rating of perceived stress will be taken from participants during the last 30 seconds of the mental stress test.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in renal vascular resistance during acute exercise
Time Frame: Pre-acute exercise and during steady-state exercise
For the acute exercise intervention, the percent change from pre-acute exercise to during steady-state exercise will be assessed.
Pre-acute exercise and during steady-state exercise
Change in renal vascular resistance during cold pressor test
Time Frame: Pre-cold pressor test to after 30, 60, 90, and 120 seconds of cold pressor test
For the cold pressor test intervention, the percent change from pre-cold pressor test to 30-second intervals during the cold pressor test will be assessed.
Pre-cold pressor test to after 30, 60, 90, and 120 seconds of cold pressor test
Change in renal vascular resistance during mental stress test
Time Frame: Pre-mental stress test to after 1, 2, 3, 4, and 5 minutes of mental stress test
For the mental stress test intervention, the percent change from pre-mental stress test to 1-minute intervals during the mental stress test will be assessed.
Pre-mental stress test to after 1, 2, 3, 4, and 5 minutes of mental stress test

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in renal blood flow velocity during acute exercise
Time Frame: Pre-acute exercise and during steady-state exercise
For the acute exercise intervention, the absolute change from pre-acute exercise to during steady-state exercise will be assessed.
Pre-acute exercise and during steady-state exercise
Change in mean arterial blood pressure during acute exercise
Time Frame: Pre-acute exercise and during steady-state exercise
For the acute exercise intervention, the absolute change from pre-acute exercise to during steady-state exercise will be assessed.
Pre-acute exercise and during steady-state exercise
Change in systolic blood pressure during acute exercise
Time Frame: Pre-acute exercise and during steady-state exercise
For the acute exercise intervention, the absolute change from pre-acute exercise to during steady-state exercise will be assessed.
Pre-acute exercise and during steady-state exercise
Change in diastolic blood pressure during acute exercise
Time Frame: Pre-acute exercise and during steady-state exercise
For the acute exercise intervention, the absolute change from pre-acute exercise to during steady-state exercise will be assessed.
Pre-acute exercise and during steady-state exercise
Change in heart rate during acute exercise
Time Frame: Pre-acute exercise and during steady-state exercise
For the acute exercise intervention, the absolute change from pre-acute exercise to during steady-state exercise will be assessed.
Pre-acute exercise and during steady-state exercise
Change in cardiac output during acute exercise
Time Frame: Pre-acute exercise and during steady-state exercise
For the acute exercise intervention, the absolute change from pre-acute exercise to during steady-state exercise will be assessed.
Pre-acute exercise and during steady-state exercise
Change in stroke volume during acute exercise
Time Frame: Pre-acute exercise and during steady-state exercise
For the acute exercise intervention, the absolute change from pre-acute exercise to during steady-state exercise will be assessed.
Pre-acute exercise and during steady-state exercise
Change in total peripheral resistance during acute exercise
Time Frame: Pre-acute exercise and during steady-state exercise
For the acute exercise intervention, the absolute change from pre-acute exercise to during steady-state exercise will be assessed.
Pre-acute exercise and during steady-state exercise
Change in renal blood flow velocity during cold pressor test
Time Frame: Pre-cold pressor test to after 30, 60, 90, and 120 seconds of cold pressor test
For the cold pressor test intervention, the absolute change from pre-cold pressor test to 30-second intervals during the cold pressor test will be assessed.
Pre-cold pressor test to after 30, 60, 90, and 120 seconds of cold pressor test
Change in mean arterial blood pressure during cold pressor test
Time Frame: Pre-cold pressor test to after 30, 60, 90, and 120 seconds of cold pressor test
For the cold pressor test intervention, the absolute change from pre-cold pressor test to 30-second intervals during the cold pressor test will be assessed.
Pre-cold pressor test to after 30, 60, 90, and 120 seconds of cold pressor test
Change in systolic blood pressure during cold pressor test
Time Frame: Pre-cold pressor test to after 30, 60, 90, and 120 seconds of cold pressor test
For the cold pressor test intervention, the absolute change from pre-cold pressor test to 30-second intervals during the cold pressor test will be assessed.
Pre-cold pressor test to after 30, 60, 90, and 120 seconds of cold pressor test
Change in diastolic blood pressure during cold pressor test
Time Frame: Pre-cold pressor test to after 30, 60, 90, and 120 seconds of cold pressor test
For the cold pressor test intervention, the absolute change from pre-cold pressor test to 30-second intervals during the cold pressor test will be assessed.
Pre-cold pressor test to after 30, 60, 90, and 120 seconds of cold pressor test
Change in heart rate during cold pressor test
Time Frame: Pre-cold pressor test to after 30, 60, 90, and 120 seconds of cold pressor test
For the cold pressor test intervention, the absolute change from pre-cold pressor test to 30-second intervals during the cold pressor test will be assessed.
Pre-cold pressor test to after 30, 60, 90, and 120 seconds of cold pressor test
Change in cardiac output during cold pressor test
Time Frame: Pre-cold pressor test to after 30, 60, 90, and 120 seconds of cold pressor test
For the cold pressor test intervention, the absolute change from pre-cold pressor test to 30-second intervals during the cold pressor test will be assessed.
Pre-cold pressor test to after 30, 60, 90, and 120 seconds of cold pressor test
Change in stroke volume during cold pressor test
Time Frame: Pre-cold pressor test to after 30, 60, 90, and 120 seconds of cold pressor test
For the cold pressor test intervention, the absolute change from pre-cold pressor test to 30-second intervals during the cold pressor test will be assessed.
Pre-cold pressor test to after 30, 60, 90, and 120 seconds of cold pressor test
Change in total peripheral resistance during cold pressor test
Time Frame: Pre-cold pressor test to after 30, 60, 90, and 120 seconds of cold pressor test
For the cold pressor test intervention, the absolute change from pre-cold pressor test to 30-second intervals during the cold pressor test will be assessed.
Pre-cold pressor test to after 30, 60, 90, and 120 seconds of cold pressor test
Change in renal blood flow velocity during mental stress test
Time Frame: Pre-mental stress test to after 1, 2, 3, 4, and 5 minutes of mental stress test
For the mental stress test intervention, the absolute change from pre-mental stress test to 1-minute intervals during the mental stress test will be assessed.
Pre-mental stress test to after 1, 2, 3, 4, and 5 minutes of mental stress test
Change in mean arterial blood pressure during mental stress test
Time Frame: Pre-mental stress test to after 1, 2, 3, 4, and 5 minutes of mental stress test
For the mental stress test intervention, the absolute change from pre-mental stress test to 1-minute intervals during the mental stress test will be assessed.
Pre-mental stress test to after 1, 2, 3, 4, and 5 minutes of mental stress test
Change in systolic blood pressure during mental stress test
Time Frame: Pre-mental stress test to after 1, 2, 3, 4, and 5 minutes of mental stress test
For the mental stress test intervention, the absolute change from pre-mental stress test to 1-minute intervals during the mental stress test will be assessed.
Pre-mental stress test to after 1, 2, 3, 4, and 5 minutes of mental stress test
Change in diastolic blood pressure during mental stress test
Time Frame: Pre-mental stress test to after 1, 2, 3, 4, and 5 minutes of mental stress test
For the mental stress test intervention, the absolute change from pre-mental stress test to 1-minute intervals during the mental stress test will be assessed.
Pre-mental stress test to after 1, 2, 3, 4, and 5 minutes of mental stress test
Change in heart rate during mental stress test
Time Frame: Pre-mental stress test to after 1, 2, 3, 4, and 5 minutes of mental stress test
For the mental stress test intervention, the absolute change from pre-mental stress test to 1-minute intervals during the mental stress test will be assessed.
Pre-mental stress test to after 1, 2, 3, 4, and 5 minutes of mental stress test
Change in cardiac output during mental stress test
Time Frame: Pre-mental stress test to after 1, 2, 3, 4, and 5 minutes of mental stress test
For the mental stress test intervention, the absolute change from pre-mental stress test to 1-minute intervals during the mental stress test will be assessed.
Pre-mental stress test to after 1, 2, 3, 4, and 5 minutes of mental stress test
Change in stroke volume during mental stress test
Time Frame: Pre-mental stress test to after 1, 2, 3, 4, and 5 minutes of mental stress test
For the mental stress test intervention, the absolute change from pre-mental stress test to 1-minute intervals during the mental stress test will be assessed.
Pre-mental stress test to after 1, 2, 3, 4, and 5 minutes of mental stress test
Change in total peripheral resistance during mental stress test
Time Frame: Pre-mental stress test to after 1, 2, 3, 4, and 5 minutes of mental stress test
For the mental stress test intervention, the absolute change from pre-mental stress test to 1-minute intervals during the mental stress test will be assessed.
Pre-mental stress test to after 1, 2, 3, 4, and 5 minutes of mental stress test

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rating of perceived exertion during acute exercise
Time Frame: During last 30 seconds of steady-state exercise
For the acute exercise intervention, the rating will be taken during the last 30 seconds of steady-state exercise. The Borg Scale of Perceived Exertion will be used, with which a rating from 6 to 20 will be taken, with 6 representing no exertion and 20 representing maximal exertion.
During last 30 seconds of steady-state exercise
Rating of hand pain during cold pressor test
Time Frame: During last 30 seconds of cold pressor test
For the cold pressor test intervention, the rating will be taken during the last 30 seconds of the cold pressor test. A scale from 0 to 10 will be used to take the rating, with 0 representing no pain and 10 representing the worst possible pain.
During last 30 seconds of cold pressor test
Rating of cold perception during cold pressor test
Time Frame: During last 30 seconds of cold pressor test
For the cold pressor test intervention, the rating will be taken during the last 30 seconds of the cold pressor test. A scale from 0 to -11 will be used to take the rating, with 0 representing no perceived cold and -11 representing unbearable cold.
During last 30 seconds of cold pressor test
Rating of perceived stress during mental stress test
Time Frame: During last 30 seconds of mental stress test
For the mental stress test intervention, the rating will be taken during the last 30 seconds of the mental stress test. A scale from 0 to 4 will be used to take the rating, with 0 representing no perceived stress and 4 representing extremely stressful.
During last 30 seconds of mental stress test

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Rachel C Drew, PhD, University of Massachusetts, Boston

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 30, 2024

Primary Completion (Estimated)

April 1, 2026

Study Completion (Estimated)

April 1, 2026

Study Registration Dates

First Submitted

June 4, 2019

First Submitted That Met QC Criteria

June 6, 2019

First Posted (Actual)

June 11, 2019

Study Record Updates

Last Update Posted (Estimated)

December 24, 2025

Last Update Submitted That Met QC Criteria

December 22, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on Acute exercise

Subscribe